Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRC-4016 (Icosabutate) in Hypertriglyceridemia
NCT01893515Phase 2Completed
- Sponsor
- Pronova BioPharma
- Start
- Jul 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of icosabutate in hypertriglyceridemia, sponsored by Pronova BioPharma. Started Jul 2013; status: completed.
02
Drugs
icosabutate
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01893515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01893515.